Medivation, Inc. Logo Image

Medivation, Inc.

Medivation, Inc. Banner Image

Most Recent Annual Report

2014 Form 10K, 2015 Annual Report

Medivation, Inc.

Medivation, Inc. does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

About Medivation, Inc.

501-1000 Employees
Based in San Francisco, California

Medivation, Inc., a biopharmaceutical company, focuses on developing novel small molecule drugs for the treatment of serious diseases in the United States and Europe. The company’s lead development candidate includes MDV3100, a molecule, which is in Phase-III development for the treatment of castration-resistant prostate cancer.

Ticker:
MDVN
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol